Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OMER
Stock Latest News
The Fly
Sagimet Biosciences appoints Grauer as Chief Medical Officer
11d ago
OMER
SGMT
Premium
The Fly
Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA
15d ago
OMER
Premium
Company Announcements
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
27d ago
OMER
Premium
The Fly
Closing Bell Movers: Nike slides 9% after Q3 results, soft outlook
1M ago
RH
NKE
Premium
The Fly
Omeros reports Q4 EPS $1.22, consensus 36c
1M ago
OMER
Premium
Pre-Earnings
Omeros Corporation (OMER) Q4 Earnings Cheat Sheet
2M ago
OMER
Premium
Ratings
Omeros: YARTEMLEA Cash Flows Funding High-Upside OncotoX-AML Pipeline, Supporting Buy Rating and $40 Target
2M ago
OMER
Premium
The Fly
Omeros announces completion of nonhuman primates OncotoX-AML study
2M ago
OMER
Premium
The Fly
Omeros announces first commercial sales of Yartemlea
3M ago
OMER
Premium
Ratings
Balanced Risk/Reward and Gradual Yartemlea Ramp Justify Hold Rating on Omeros
4M ago
OMER
Premium
The Fly
Omeros price target raised to $40 from $20 at H.C. Wainwright
4M ago
OMER
Premium
The Fly
Omeros call volume above normal and directionally bullish
4M ago
OMER
Premium
The Fly
Omeros call volume above normal and directionally bullish
4M ago
OMER
Premium
The Fly
D. Boral Capital notes Omeros’ YARTEMLEA FDA win, maintains Buy rating
4M ago
OMER
Premium
Ratings
Omeros: YARTEMLEA Approval and Novo Nordisk Partnership Drive Re‑Rating Potential and Support Buy Rating
4M ago
OMER
Premium
The Fly
H.C. Wainwright says Yartemlea approval ‘significant validation’ of Omeros value
4M ago
OMER
Premium
The Fly
Omeros trading resumes
4M ago
OMER
Premium
The Fly
Omeros trading halted, volatility trading pause
4M ago
OMER
Premium
The Fly
Omeros up 100% at $17.55 upon resumption of trading
4M ago
OMER
Premium
The Fly
Omeros to resume trading at 9:50 am ET
4M ago
OMER
Premium
The Fly
Omeros announces FDA approved YARTEMLE for treatment of TA-TMA
4M ago
OMER
Premium
The Fly
Omeros trading halted, news pending
4M ago
OMER
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
